In cancer, dihydrofolate reductase (DHFR) is competitively inhibited whereas in RA inhibition of DHFR is not the main mechanism but multiple different and complex actions seem to be involved [13, 14]. This evidence concerns the gene DHFR and rheumatoid arthritis.